scholarly article | Q13442814 |
P356 | DOI | 10.1002/DVDY.10479 |
P8608 | Fatcat ID | release_wd4g5axnljgwvccovhgzsfw2d4 |
P698 | PubMed publication ID | 14991706 |
P5875 | ResearchGate publication ID | 5656299 |
P50 | author | Nicole L. Ward | Q42131708 |
P2093 | author name string | Daniel J Dumont | |
Paul Van Slyke | |||
Celina Sturk | |||
Maribelle Cruz | |||
P2860 | cites work | The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction. | Q51715205 |
Conditional transgene expression in endothelial cells. | Q52176912 | ||
Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. | Q52214194 | ||
Conditional transgene expression in the heart | Q71590968 | ||
N-cadherin involvement in cardiac myocyte interaction and myofibrillogenesis | Q72286021 | ||
Increased vascularization in mice overexpressing angiopoietin-1 | Q77418701 | ||
Angiopoietins 3 and 4: diverging gene counterparts in mice and humans | Q22008836 | ||
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning | Q24310148 | ||
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis | Q24313372 | ||
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation | Q24316945 | ||
The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development | Q24605541 | ||
Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration | Q28145912 | ||
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis | Q28300359 | ||
Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function | Q28365924 | ||
Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function | Q28505330 | ||
Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 | Q28513759 | ||
Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo | Q28586040 | ||
FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium | Q28587401 | ||
M-cadherin and its sisters in development of striated muscle | Q33592129 | ||
VEGFs, receptors and angiogenesis | Q33644265 | ||
Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). | Q34032032 | ||
Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha -/- mice. | Q34051459 | ||
The cadherin-catenin adhesion system in signaling and cancer | Q34124023 | ||
Cellular interactions in vascular growth and differentiation | Q34177719 | ||
Eph receptors and ephrin ligands. essential mediators of vascular development. | Q34204669 | ||
Developmental roles of platelet-derived growth factors | Q34269318 | ||
The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis | Q34498133 | ||
Vascular patterning by Eph receptor tyrosine kinases and ephrins | Q34611029 | ||
Mechanisms of embryonic coronary artery development | Q34641873 | ||
Development of the coronary blood supply: changing concepts and current ideas | Q34810697 | ||
Development of the coronary vessel system | Q34986182 | ||
A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function | Q35895986 | ||
P433 | issue | 3 | |
P304 | page(s) | 500-509 | |
P577 | publication date | 2004-03-01 | |
P1433 | published in | Developmental Dynamics | Q59752 |
P1476 | title | Angiopoietin 1 expression levels in the myocardium direct coronary vessel development | |
P478 | volume | 229 |
Q35103148 | Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease. |
Q51772632 | Angiopoietin-1 for myocardial angiogenesis: a comparison between delivery strategies. |
Q45866244 | Cell-based angiopoietin-1 gene therapy for acute lung injury. |
Q54506625 | Chapter 9. Development of coronary vessels. |
Q37534988 | Coronary vessel development and insight towards neovascular therapy. |
Q35937605 | Development of coronary vessels |
Q36387870 | Endothelial-cardiomyocyte interactions in cardiac development and repair |
Q36081721 | Enhanced expression of VEGF-A in β cells increases endothelial cell number but impairs islet morphogenesis and β cell proliferation. |
Q24303956 | Epicardial-myocardial signaling directing coronary vasculogenesis |
Q37998444 | Importance of myocyte-nonmyocyte interactions in cardiac development and disease |
Q35909145 | Niaspan increases axonal remodeling after stroke in type 1 diabetes rats |
Q47442360 | Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies |
Q39012408 | Prospects for improving neovascularization of the ischemic heart: Lessons from development |
Q41903030 | Tbx18 regulates development of the epicardium and coronary vessels. |
Q37687321 | The epicardium as a candidate for heart regeneration. |
Q37799410 | The epicardium in cardiac repair: From the stem cell view |
Q36052725 | The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems. |
Q35511977 | Therapeutic Benefit of Extended Thymosin β4 Treatment Is Independent of Blood Glucose Level in Mice with Diabetic Peripheral Neuropathy |
Q92185709 | Tie2 regulates endocardial sprouting and myocardial trabeculation |
Q45250508 | Vascular-specific growth factor angiopoietin 1 is involved in the organization of neuronal processes |
Search more.